Making More Exosomes for Heart Treatment
Author Information
Author(s): Chen Tian Sheng, Arslan Fatih, Yin Yijun, Tan Soon Sim, Lai Ruenn Chai, Choo Andre Boon Hwa, Padmanabhan Jayanthi, Lee Chuen Neng, de Kleijn Dominique PV, Lim Sai Kiang
Primary Institution: Institute of Medical Biology, A*STAR
Hypothesis
Can MYC immortalization of hESC-derived MSCs allow for continuous production of therapeutic exosomes without compromising their efficacy?
Conclusion
MYC transformation allows for an infinite supply of cells to produce therapeutic exosomes, which can reduce heart damage in mice.
Supporting Evidence
- MYC-transformed MSCs maintained the ability to produce therapeutic exosomes.
- Exosomes from MYC-transformed MSCs significantly reduced infarct size in a mouse model.
- The transformation allowed for faster cell growth and reduced production costs.
Takeaway
Scientists found a way to make more tiny helpers called exosomes that can protect the heart, by changing some cells so they never get old.
Methodology
The study involved transfecting hESC-derived MSCs with a MYC gene and analyzing the transformed cells for various characteristics and their ability to produce exosomes.
Potential Biases
Potential risks associated with the use of lentiviral vectors for cell transformation.
Limitations
The transformed cells lost the ability to undergo adipogenic differentiation, which is a key characteristic of MSCs.
Statistical Information
P-Value
p < 0.001
Statistical Significance
p < 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website